What did Jefferies do on March 05, 2026 for Verastem (VSTM)?

Jefferies reaffirmed a **Buy** rating on Verastem (VSTM) on March 05, 2026, and maintained a **$19.00** price target. The note cited launch progress and a catalyst-rich 2026 as reasons for the reiteration.

How should investors interpret the VSTM analyst rating?

A maintained Buy means analysts see upside if Verastem executes on launches and trials. It signals confidence but not certainty, so investors should track milestones and cash runway before adjusting positions.

Does the VSTM analyst rating include a price target?

Yes. Jefferies kept a **$19.00** price target in the March 05, 2026 note. Price targets give a valuation reference but depend on future trial outcomes and commercial performance.

What is Meyka AI’s view on the VSTM analyst rating?

Meyka AI rates VSTM **B+** and views Jefferies’ reiteration as supportive but not decisive. The grade factors in benchmarks, sector performance, financial growth, metrics, and analyst consensus.

Analyst Ratings

Jefferies Maintains Buy on Verastem, Inc. (VSTM) March 2026

ByHuzaifa Zahoor March 6, 2026

Jefferies maintained its Buy rating on Verastem, Inc. (VSTM) on March 05, 2026, citing a “catalyst-rich 2026.” The VSTM analyst rating was reiterated amid launch progress and revenue growth signals. Jefferies also kept a $19.00 price target, per Investing.com, and StreetInsider reported the note on March 05, 2026. Meyka AI rates VSTM with a grade of B+. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors.